Tango Therapeutics
Investors
Join Us
Contact
Science
Approach
Platform
Publications + Posters
Pipeline
Programs
PRMT5
CoREST
USP1
Clinical Trials
Leadership
Home
Science
▼
Approach
Platform
Publications + Posters
Pipeline
Programs
▼
PRMT5
CoREST
USP1
Clinical Trials
Leadership
Join Us
Investors
▼
Overview
News & Events
News Releases
Events & Presentations
Governance
Overview
Executive Leadership
Board of Directors
Committee Composition
Stock Information
Stock Quote & Chart
Financials
SEC Filings
Resources
▼
Investor FAQs
Email Alerts
Contact IR
Contact
New Cambridge biotech Tango aims to make cancer its own worst enemy
Press Release
New Cambridge biotech Tango aims to make cancer its own worst enemy
